This inventor holds 3 USPTO granted patents. Top assignee: Syntex (u.s.a.) Inc.. Active years: 1998-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2006
Title: Renu Anand Heller: Innovator in Aggrecanase Research
Introduction
Renu Anand Heller is a notable inventor based in Stanford, CA (US). She has made significant contributions to the field of biomedical research, particularly in the area of aggrecanase and its implications in various diseases. With a total of 3 patents, her work has paved the way for advancements in therapeutic applications.
Latest Patents
Heller's latest patents include groundbreaking inventions related to human aggrecanase and nucleic acid compositions encoding the same. These inventions provide polypeptides and nucleic acid compositions that are useful in research, diagnostics, and therapeutic agent screening applications. Additionally, she has developed methods for inhibiting aggrecanase activity in hosts, which can be crucial for treating disease conditions such as rheumatoid arthritis, osteoarthritis, and other related ailments. Another significant patent involves methods for measuring stromelysin-1 promoter activity, which includes a purified DNA containing a functional HSL-1 promoter region. This invention has applications in pharmacologic screening assays and methods for modulating TNF α levels in inflamed tissues.
Career Highlights
Renu Anand Heller has had a distinguished career, working with Syntex (U.S.A.) Inc. Her innovative research has led to advancements in understanding and treating diseases associated with aggrecanase activity. Her work is recognized for its potential impact on therapeutic strategies in the biomedical field.
Collaborations
Heller has collaborated with notable colleagues, including Paula Ann Borden and John David Allard. These collaborations have further enriched her research and contributed to the development of her patents.
Conclusion
Renu Anand Heller's contributions to the field of biomedical research, particularly in aggrecanase, highlight her role as an influential inventor. Her patents not only advance scientific understanding but also hold promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile